Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS
Clinical trial NCT04165850 · COMPLETED
Trial details
- NCT number
- NCT04165850
- Sponsor
- NeuroSense Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2021-01-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.